Fast Tracked New Customer Reviews When a product is Fast Tracked, the sponsor can request meetings at several stages—pre-IND, End of Phase 1, End of Phase 2, and pre-NDA/BLA—so that the Fast Tracked program supports iterative course corrections and alignment on the evidence the FDA expects to see, and these meetings typically result in minutes and written guidance that the sponsor can use to refine protocols and statistical plans. Fast Tracked’s rolling review feature allows the FDA to begin evaluating portions of a submission as they are completed rather than waiting for a full application; this means the FDA can start reviewing chemistry, manufacturing and controls data, clinical study reports, and other modules earlier, which often reduces the queue time once the final submission is filed—companies using Fast Tracked can therefore plan for manufacturing and commercial readiness with less uncertainty. The Fast Tracked designation also makes a product more likely to be considered for Priority Review, though not guaranteed, and underlining that Fast Tracked is an entry point to other expedited pathways clarifies why many sponsors pursue Fast Tracked early: Fast Tracked can be granted on the basis of nonclinical studies or strong mechanistic rationale, whereas Breakthrough Therapy requires preliminary clinical evidence of substantial improvement, so Fast Tracked is accessible earlier in development to programs addressing serious conditions with unmet needs.
Fast Tracked New Customer Reviews Fast Tracked benefits a wide spectrum of stakeholders: pharmaceutical and biotechnology companies gain clearer regulatory direction and often faster approvals, patient advocates see earlier access to promising treatments, and clinicians obtain new options for hard-to-treat diseases; Fast Tracked thus aligns regulatory effort with medical need. Sponsors should also ensure operational readiness—Fast Tracked accelerates timelines but does not reduce the workload, and companies must be prepared to submit rolling review modules, scale manufacturing, and plan confirmatory studies when needed. For advisors and consultants, recommending Fast Tracked requires an honest assessment of the evidence and a clear plan for using Fast Tracked’s meeting cadence and rolling submission process to resolve regulatory questions early; in the right circumstances Fast Tracked can materially improve the probability of timely approval and patient access. Order Now Fast Tracked Reviews and Complaints BBB